Back

WMHs AND HOMOCYSTEINE LEVELS AS CANDIDATE BIOMARKER FOR COGNITIVE IMPAIRMENT

Misra, V.; Krishnamoorthy, E. S.; Balaji, S.; K, J.; K, N.

2020-05-08 neurology
10.1101/2020.05.04.20090704 medRxiv
Show abstract

The aim of this pilot study was to test the hypotheses that a) WMHs would be a biological marker in South Indian patients who present with either cognitive impairment, dementia or depression and b) presence of WMHs would be related to other blood biochemical markers. A significant positive correlation was present between temporal WMHs and increased homocysteine levels. A significant inverse correlation was obtained between MMSE scores and frontal caps. Association between temporal WMHs and elevated plasma homocysteine levels implies that this can serve as a biological marker for cognitive impairment and possibly for therapy.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.